Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - ANAVEX LIFE SCIENCES CORP. | s114606_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ANAVEX LIFE SCIENCES CORP. | s114606_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ANAVEX LIFE SCIENCES CORP. | s114606_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - ANAVEX LIFE SCIENCES CORP. | s114606_ex21-1.htm |
| 10-K - FORM 10-K - ANAVEX LIFE SCIENCES CORP. | s114606_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Anavex Life Sciences Corp.
New York, New York
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-218292 and 333-207600) and the Registration Statement on Form S-8 (No. 333-219934) of our reports dated December 12, 2018, relating to the consolidated financial statements, and the effectiveness of Anavex Life Sciences Corp.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
New York, New York
December 12, 2018